New treatment for osteoarthritis using nanomedicine to replace steroids
Macrophage Anchoring Nanomedicine to Replace Steroids for Intra-articular Injection
This study is exploring a new treatment for osteoarthritis that uses tiny particles to help reduce joint inflammation and protect cartilage, aiming to offer longer-lasting relief than regular steroid medications.
Quick facts
| Grant type | R21 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Virginia NIH-funded |
| Lab location | 1 site (Charlottesville, United States) |
| Project ID | NIH-10809035 on NIH RePORTER |
What this research studies
This research investigates a novel nanomedicine approach to treat osteoarthritis (OA) by using a specially designed nanoplatform that targets inflammation in the joints. The study aims to evaluate the effectiveness of this nanomedicine in human joint samples and in mouse models, focusing on its ability to reduce inflammation and prevent cartilage damage. By enhancing the retention of therapeutic agents in the joint, this approach seeks to provide longer-lasting relief from OA symptoms compared to traditional steroid treatments.
Who could benefit from this research
Good fit: Ideal candidates for this research are adults aged 21 and older who are experiencing symptoms of osteoarthritis.
Not a fit: Patients with conditions other than osteoarthritis or those who are not responsive to anti-inflammatory treatments may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could offer a more effective and longer-lasting treatment option for patients suffering from osteoarthritis.
How similar studies have performed: Previous research has shown promising results with nanomedicine approaches in treating inflammatory conditions, suggesting potential success for this novel method.
Where this research is happening
Charlottesville, United States
- University of Virginia — Charlottesville, United States (Active)
Researchers
- Principal investigator: Jin, Li — University of Virginia
- Study coordinator: Jin, Li
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.